Stopping the Control Arm in Response to the DSMB: Mother’s Choice of HIV Prophylaxis during Breastfeeding in the BAN Study

Chavula, Charity; Long, Dustin; Mzembe, Enalla; Kayira, Dumbani; Chasela, Charles; Hudgens, Michael G.; Hosseinipour, Mina; King, Caroline C.; Ellington, Sascha; Chigwenembe, Margret; Jamieson, Denise J.; van der Horst, Charles

doi:10.1016/j.cct.2011.10.006

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Stopping the Control Arm in Response to the DSMB: Mother’s Choice of HIV Prophylaxis during Breastfeeding in the BAN Study

Published Date:

Oct 25 2011

Publisher's site:

http://dx.doi.org/10.1016/j.cct.2011.10.006 New Site Icon

Source:

Contemp Clin Trials. 33(1):55-59.

[PDF-297.45 KB]

Details:

Personal Authors:

Chavula, Charity ; Long, Dustin ; Mzembe, Enalla ; Kayira, Dumbani ; Chasela, Charles ; ... More ▼

Corporate Authors:

for the BAN Study Team

Keywords:

[+]

Pubmed ID:

22041453

Pubmed Central ID:

PMC3253884

Description:

The Data and Safety Monitoring Board (DSMB) for the Breastfeeding, Antiretrovirals, and Nutrition study, a clinical trial aimed to prevent postnatal HIV transmission, recommended halting randomization to the enhanced standard-of-care (control) arm. The 67 mother-infant pairs on the control arm and less than 21 weeks postpartum at the time of the DSMB recommendation were read a script informing them of the DSMB decision and offering them the maternal or infant antiretroviral interventions for the remainder of the 28-week breastfeeding period. This paper describes the BAN study response to the DSMB decision and what the women on the control arm chose, when given a choice to start the maternal or infant antiretroviral interventions.

Document Type:

Journal Article

Collection(s):

CDC Public Access

Funding:

2-D43 TW01039-06/TW/FIC NIH HHS/United States
P30 AI050410/AI/NIAID NIH HHS/United States
P30 AI050410-15/AI/NIAID NIH HHS/United States
P30-AI50410/AI/NIAID NIH HHS/United States
R24 TW00798/TW/FIC NIH HHS/United States
SIP 13-01 U48-CCU409660-09/PHS HHS/United States
SIP 22-09 U48-DP001944-01/DP/NCCDPHP CDC HHS/United States
SIP 26-04 U48-DP000059-01/DP/NCCDPHP CDC HHS/United States

Supporting Files:

	nihms334336.nxml	application/octet-stream
	nihms334336f1.gif	image/gif
	nihms334336f1.jpg	image/jpeg

No Related Documents.

You May Also Like:

Delayed HIV detection among infants exposed to postnatal antiretroviral prophylaxis during breastfeeding

Personal Author:

King, Caroline C.; Kourtis, Athena P.; Persaud, Deborah; Nelson, Julie A.E.; Ziemniak, Carrie; Hudgens, Michael G.; Tegha, Gerald; Chasela, Charles S.; Jamieson, Denise J.; van der Horst, Charles M.;

Published:

Sep 24 2015

Source:

AIDS. 29(15):1953-1961.

Description:

Objective : The objective of this study is to determine whether detection of HIV infection was delayed in infants exposed to antiretroviral prophylaxis to prevent HIV transmission during breastfeeding. : Design : The Breastfeeding, Antiretrovirals an...

File Type:

[PDF - 608.86 KB]
Antiretroviral treatment is associated with iron deficiency in HIV-infected Malawian women that is mitigated with supplementation, but is not associated with infant iron deficiency during 24 weeks of exclusive breastfeeding

Personal Author:

Widen, Elizabeth M.; Bentley, Margaret E.; Chasela, Charles S.; Kayira, Dumbani; Flax, Valerie L.; Kourtis, Athena P.; Ellington, Sascha R.; Kacheche, Zebrone; Tegha, Gerald; Jamieson, Denise J.; van der Horst, Charles M.; Allen, Lindsay H.; Shahab-Ferdows, Setareh; Adair, Linda S.;

Published:

Jul 1 2015

Source:

J Acquir Immune Defic Syndr. 69(3):319-328.

Description:

Objective : In resource-limited settings without safe alternatives to breastfeeding, the WHO recommends exclusive breastfeeding and antiretroviral (ARV) prophylaxis. Given the high prevalence of anemia among HIV-infected women, mothers and their infa...

File Type:

[PDF - 396.53 KB]
Prevention of mother-to-child transmission of Human Immunodeficiency Virus Type 1 (HIV): the role of neonatal and infant prophylaxis

Personal Author:

Hurst, Stacey A.; Appelgren, Kristie E.; Kourtis, Athena P.;

Published:

Feb 2015

Source:

Expert Rev Anti Infect Ther. 13(2):169-181.

Description:

The prevention of mother-to-child transmission (PMTCT) of HIV is one of the great public health successes of the past 20 years. Much concerted research efforts and dedicated work have led to the achievement of very low rates of PMTCT of HIV in settin...

File Type:

[PDF - 166.63 KB]
Health outcomes of HIV-exposed uninfected African infants

Personal Author:

Kourtis, Athena P.; Wiener, Jeffrey; Kayira, Dumbani; Chasela, Charles; Ellington, Sascha R.; Hyde, Lisa; Hosseinipour, Mina; van der Horst, Charles; Jamieson, Denise J.;

Published:

Mar 13 2013

Source:

AIDS. 2013; 27(5):749-759.

Description:

Objectives : To evaluate severe (grade 3/4) morbidity and mortality in HIV-exposed, uninfected infants. : Design : Secondary data analysis of The Breastfeeding, Antiretrovirals, and Nutrition (BAN) clinical trial. : Methods : BAN randomized 2369 moth...

File Type:

[PDF - 420.04 KB]
Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial

Personal Author:

Jamieson, Denise J.; Chasela, Charles S.; Hudgens, Michael G.; King, Caroline C.; Kourtis, Athena P.; Kayira, Dumbani; Hosseinipour, Mina C.; Kamwendo, Deborah D.; Ellington, Sascha R.; Wiener, Jeffrey B.; Fiscus, Susan A.; Tegha, Gerald; Mofolo, Innocent A.; Sichali, Dorothy S.; Adair, Linda S.; Knight, Rodney J.; Martinson, Francis; Kacheche, Zebrone; Soko, Alice; Hoffman, Irving; van der Horst, Charles;

Corporate Author:

The BAN study team

Published:

Apr 26 2012

Source:

Lancet. 379(9835):2449-2458.

Description:

Background : In resource-limited settings where no safe alternative to breastfeeding exists, WHO recommends that antiretroviral prophylaxis be given to either HIV-infected mothers or infants throughout breastfeeding. We assessed the effect of 28 week...

File Type:

[PDF - 646.80 KB]